Guggenheim lowered the firm’s price target on Endava (DAVA) to $18 from $20 and keeps a Buy rating on the shares, though the analyst removed the stock as his “Best Idea” as business momentum will likely take time to materialize. Underperformance in the quarter and a softer-than-expected FY26 outlook “signal the confluence of macroeconomic headwinds,” but management’s conservatism in its FY26 outlook “appears compelling,” the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVA:
- Endava Reports Strong Financial Growth Amid Market Expansion
- Endava’s Earnings Call: Mixed Sentiment Amid Achievements and Challenges
- Endava’s Strategic Overhaul Amid Market Challenges: Hold Rating Maintained
- Salesforce slides, Figma flops after earnings: Morning Buzz
- Morning Movers: Ciena jumps following third quarter earnings report